Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease

5-methylcytosine and the oxidation product 5-hydroxymethylcytosine are two prominent epigenetic variants of the cytosine base in nuclear DNA of mammalian brains. We measured levels of 5-methylcytosine and 5-hydroxymethylcytosine by enzyme-linked immunosorbent assay in DNA from post-mortem cerebella...

Full description

Bibliographic Details
Main Authors: Stöger, Reinhard, Scaife, Paula, Shephard, Freya, Chakrabarti, Lisa
Format: Article
Published: Nature Publishing Group 2017
Subjects:
Online Access:https://eprints.nottingham.ac.uk/40271/
_version_ 1848796022183034880
author Stöger, Reinhard
Scaife, Paula
Shephard, Freya
Chakrabarti, Lisa
author_facet Stöger, Reinhard
Scaife, Paula
Shephard, Freya
Chakrabarti, Lisa
author_sort Stöger, Reinhard
building Nottingham Research Data Repository
collection Online Access
description 5-methylcytosine and the oxidation product 5-hydroxymethylcytosine are two prominent epigenetic variants of the cytosine base in nuclear DNA of mammalian brains. We measured levels of 5-methylcytosine and 5-hydroxymethylcytosine by enzyme-linked immunosorbent assay in DNA from post-mortem cerebella of individuals with Parkinson’s disease and age-matched controls. 5-methylcytosine levels showed no significant differences between Parkinson’s disease and control DNA sample sets. In contrast, median 5-hydroxymethylcytosine levels were almost twice as high (p < 0.001) in both male and female Parkinson’s disease individuals compared with controls. The distinct epigenetic profile identified in cerebellar DNA of Parkinson’s disease patients raises the question whether elevated 5-hydroxymethylcytosine levels are a driver or a consequence of Parkinson’s disease.
first_indexed 2025-11-14T19:41:22Z
format Article
id nottingham-40271
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:41:22Z
publishDate 2017
publisher Nature Publishing Group
recordtype eprints
repository_type Digital Repository
spelling nottingham-402712024-08-15T15:21:23Z https://eprints.nottingham.ac.uk/40271/ Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease Stöger, Reinhard Scaife, Paula Shephard, Freya Chakrabarti, Lisa 5-methylcytosine and the oxidation product 5-hydroxymethylcytosine are two prominent epigenetic variants of the cytosine base in nuclear DNA of mammalian brains. We measured levels of 5-methylcytosine and 5-hydroxymethylcytosine by enzyme-linked immunosorbent assay in DNA from post-mortem cerebella of individuals with Parkinson’s disease and age-matched controls. 5-methylcytosine levels showed no significant differences between Parkinson’s disease and control DNA sample sets. In contrast, median 5-hydroxymethylcytosine levels were almost twice as high (p < 0.001) in both male and female Parkinson’s disease individuals compared with controls. The distinct epigenetic profile identified in cerebellar DNA of Parkinson’s disease patients raises the question whether elevated 5-hydroxymethylcytosine levels are a driver or a consequence of Parkinson’s disease. Nature Publishing Group 2017-02-01 Article PeerReviewed Stöger, Reinhard, Scaife, Paula, Shephard, Freya and Chakrabarti, Lisa (2017) Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease. npj Parkinson's Disease, 3 (6). pp. 1-6. ISSN 2373-8057 DNA epigenetics Parkinson's disease http://www.nature.com/articles/s41531-017-0007-3 doi:10.1038/s41531-017-0007-3 doi:10.1038/s41531-017-0007-3
spellingShingle DNA
epigenetics
Parkinson's disease
Stöger, Reinhard
Scaife, Paula
Shephard, Freya
Chakrabarti, Lisa
Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
title Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
title_full Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
title_fullStr Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
title_full_unstemmed Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
title_short Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
title_sort elevated 5hmc levels characterize dna of the cerebellum in parkinson’s disease
topic DNA
epigenetics
Parkinson's disease
url https://eprints.nottingham.ac.uk/40271/
https://eprints.nottingham.ac.uk/40271/
https://eprints.nottingham.ac.uk/40271/